1232056

LGM Pharma Solutions, LLC — FEI 3017140477

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 24, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Irvine, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)